No legitimate compounded version of eloralintide is currently available, and we do not recommend obtaining investigational medications from compounding pharmacies, online clinics, or peptide vendors
In the landmark STEP-1 clinical trial, participants receiving semaglutide 2.4 mg once weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo
Patients in states with strong telehealth regulations and competitive markets see lower cash pay prices
Each has a unique pharmacological profile that dictates its own specific titration schedule
Upon securing authorization, you benefit from continuous care coordination and 24/7 support, encompassing appointment reminders, prescription updates, pharmacy support services, and readily available communication with your care team
Accepted: May 13, 2024 DOI: Download citation